Tennessee bill on hold until 2014

Article

 

By David K. Talley, OD, FAAO

President, Tennessee Association of Optometric Physicians

Optometrists in Tennessee hoped to gain legislative approval to administer injectable anesthetic while performing primary eyecare procedures of the eyelid. Currently, ODs in Tennessee are able to use topical anesthetics for procedures, such as removing skin tags, papillomas, and chalazia. To that end, both SB220 and HB555 were rolled until January 2014: SB220 was assigned to the general subcommittee of the Senate and action was deferred on HB555 in the House health subcommittee.

The legislation remains viable. Hearings took place, but no votes took place in either committee. Rolling bills until the next session is not uncommon with controversial matters. The Tennessee Association of Optometric Physicians (TAOP) will continue to work with Tennessee legislators to prepare for the January 2014 vote.

At the last minute, an intense negotiation with representatives of ophthalmology took place in an attempt to finalize a bill that everyone concerned could support. Ophthalmology’s response was not to negotiate in good faith with optometry’s representatives but to challenge optometry’s accomplishments. Several undecided legislators saw optometry’s effort to compromise with ophthalmology and were angry at ophthalmology’s unwillingness to negotiate. This recognition could help optometry in the future.

During negotiations, ophthalmology was concerned only with optometry’s current scope of practice. In fact, ophthalmology appeared to be surprised at the extent of our scope of practice. Optometry’s lobbyist pointed out the profession’s outstanding track record; however, the ophthalmology team replied that it wasn’t impressed with optometry’s track record, and it is something to sell to the legislature, not to ophthalmology.

The American Academy of Ophthalmology (AAO) stepped in and began using scare tactics. The AAO began running negative radio ads across Tennessee. AAO representatives also called patients at home to ask if they wanted optometrists performing reconstructive lid surgery.ODT

Dr. Talley is part of a group private practice in Memphis, TN.

 

Box:

SB220 and HB555 would allow ODs to utilize injectable anesthetic while performing primary eyecare procedures of the eyelid.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.